J Cancer 2011; 2:360-362. doi:10.7150/jca.2.360
Adoptive Cell Therapy for Patients with Melanoma
Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892-1201, USA
Adoptive cell therapy can be an effective treatment for some patients with advanced cancer. This report summarizes clinical trial results from the Surgery Branch, NCI, investigating tumor infiltrating lymphocytes (TIL) and gene engineered peripheral blood T cells for the therapy of patients with melanoma and other solid tumors.
Keywords: TIL, melanoma, NY-ESO-1, interleukin-2, lymphodepletion
Dudley ME. Adoptive Cell Therapy for Patients with Melanoma. J Cancer 2011; 2:360-362. doi:10.7150/jca.2.360. Available from http://www.jcancer.org/v02p0360.htm